The FDA’s standard-making process for medical digital health technologies: co-producing technological and organizational innovation
Tóm tắt
As digital health technologies (DHT) have been embraced as a ‘panacea’ for health care systems, they have evolved from a buzzword into a high priority objective for health policy across the globe. In the realm of quality and safety standards for medical devices, the US Food and Drug Administration (FDA) has been a frontrunner in adapting its regulatory framework to DHT. However, despite the utmost relevance of quality and safety standards and their role for sustaining the innovation pathway of DHT, their actual making has not yet been subjected to in-depth social-science scrutiny. Drawing on the conceptual repertoires of Science and Technology Studies (STS), this article investigates how digital health evolved from a buzzword into an ‘object of government’, or gained material meaning and transformed into a regulatable object, by charting the standard-making process of FDA’s medical digital health policy between 2008 and 2018. From this, we reflect on the mutually sustaining dynamics between technological and organizational innovation, as the FDA’s attempts to standardize medical DHT not only shaped the lifestyle/medical boundary for DHT. It also led to significant reconfigurations within the FDA itself, while fostering a broader shift toward the uptake of alternative forms of evidence in regulatory science.
Tài liệu tham khảo
Abraham, J. 1995. Science, Politics, and the Pharmaceutical Industry: Controversy and Bias in Drug Regulation. London: UCL Press.
Abraham, J., and C. Davis. 2007. Deficits, expectations and paradigms in British and American Drug Safety Assessments: prising open the Black Box of Regulatory Science. Science, Technology, & Human Values 32 (4): 399–431.
Allen, A. 2014. Health Apps boom while regs lag. Politico, 3 June. https://www.politico.com/story/2014/06/health-apps-boom-while-regs-lag-107345_Page2.html
AppleVideoArchive. 2011. Apple WWDC 2008. Youtube.com, 31 December. https://www.youtube.com/watch?reload=9&v=AHolDv1plk0
Australian Digital Health Agency. 2018. Australia’s National Digital Health Strategy. Safe, seamless and secure: evolving health and care to meet the needs of modern Australia. https://conversation.digitalhealth.gov.au/sites/default/files/adha-strategy-doc-2ndaug_0_1.pdf
Barry, A. 2001. Political Machines: Governing a Technological Society. London and New York: The Athlone Press.
Bauman, J. 2012. The ‘Déjà Vu Effect:’ evaluation of United States medical device legislation, regulation, and the Food and Drug Administration’s contentious 510(k) program. Food and Drug Law Journal 67 (3): 337–361.
Bensaude Vincent, B. 2014. The politics of buzzwords at the interface of technoscience, market and society: the case of ‘public engagement in science.’ Public Understanding of Science 23 (3): 238–253.
Blasimme, A., E. Vayena, and I. Van Hoyweghen. 2019. Big data, precision medicine and private insurance: a delicate balancing act. Big Data & Society, 1–6. https://doi.org/10.1177/2053951719830111
Brown, N. 2003. Hope against hype—accountability in biopasts. Presents and Futures. Science Studies 16 (2): 3–21.
Borup, M., et al. 2006. The sociology of expectations in science and technology. Technology Analysis & Strategic Management 18 (3–4): 285–298.
Bowker, G.C., and S.L. Star. 1999. Sorting Things Out: Classification and Its Consequences, 2nd print. Cambridge, MA: MIT press.
Businesswire. 2020. Global Digital Health Market 2020–2024. Evolving Opportunities With Alphabet Inc. and Apple Inc. Technavio. 4 March. https://www.businesswire.com/news/home/20200303005780/en/Global-Digital-Health-Market-2020-2024-Evolving-Opportunities
Callon, M. 1998. The Laws of the Markets. Oxford: Blackwell (Sociological Review Monographs).
Cambrosio, A., P. Keating, and N. Nelson. 2014. Régimes thérapeutiques et dispositifs de preuve en oncologie : l’organisation des essais cliniques, des groupes coopérateurs aux consortiums de recherche. Sciences Sociales et Santé 32 (3): 13–42.
Cambrosio, A., P. Bourret, and P. Keating. 2017. Opening the Regulatory Black Box of clinical cancer research: transnational expertise networks and ‘Disruptive’ technologies. Minerva 55 (2): 161–185.
Carpenter, D. 2010. Reputation and Power: Organizational Image and Pharmaceutical Regulation at the FDA. Princeton and Oxford: Princeton University Press.
Carver, K. 2013. Coalition Seeks to Delay Mobile Medical Apps Guidance. Updates on Development for medical devices—Covington & Burling LLP. https://www.cov.com/en/practices-and-industries/practices/regulatory-and-public-policy/food-drug-and-device/medical-devices-and-diagnostics
Cochoy, F., M. Giraudeau, and L. McFall. 2010. Performativity, economics and politics: an overview. Journal of Cultural Economy 3 (2): 139–146.
Cortez, N. 2015. Analog Agency in a Digital World. In FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies, ed. H.F. Lynch and G. Cohen. New York: Columbia University Press.
Cortez, N. 2019. Digital health and regulatory experimentation at the FDA. Yale Journal of Health Policy, Law, and Ethics 18 (3): 4–26.
Comstock, J. 2017. Apple, Fitbit, Samsung, and Verily among FDA’s picks for precertification pilot. MobiHealthNews, 26 September. https://www.mobihealthnews.com/content/apple-fitbit-samsung-and-verily-among-fdas-picks-precertification-pilot
Crawford et al. 2015. Our metrics, ourselves: a hundred years of self- tracking from the weight scale to the wrist wearable device. European Journal of Cultural Studies 18 (4–5): 479–496.
21st Century Cures Act (2016) US 114th Congress. https://www.congress.gov/bill/114th-congress/house-bill/34
Davis, C., and J. Abraham. 2011. Desperately seeking cancer drugs: explaining the emergence and outcomes of accelerated pharmaceutical regulation. Sociology of Health & Illness 33 (5): 731–747.
Deloitte. 2015. No appointment necessary: How the IoT and patient-generated data can unlock health care value. https://www2.deloitte.com/tr/en/pages/life-sciences-and-healthcare/articles/internet-of-things-iot-in-health-care-industry.html
Demortain, D. 2011. Scientists and the Regulation of Risk: Standardising Control. Cheltenham, UK: Edward Elgar Publishing.
Demortain, D. 2017. Expertise, Regulatory Science and the Evaluation of Technology and Risk: Introduction to the Special Issue. Minerva 55(2): 139.
Dolan, B. 2010. mHealth Regulatory Coalition’s first meeting. MobiHealthNews, 14 July. https://www.mobihealthnews.com/8358/update-mhealth-regulatory-coalitions-first-meeting
Dolan, B. 2011. FDA clears first diagnostic radiology app, Mobile MIM. MobiHealthNews, 4 February. https://www.mobihealthnews.com/10173/fda-clears-first-diagnostic-radiology-app-mobile-MIM
European Commission. 2014a. Green Paper on mobile Health (“mHealth”). https://ec.europa.eu/digital-single-market/en/news/green-paper-mobile-health-mhealth
European Commission. 2014b. Commission Staff Working Document on the existing EU legal framework applicable to lifestyle and wellbeing apps Accompanying the document GREEN PAPER on mobile Health (“mHealth”). https://op.europa.eu/en/publication-detail/-/publication/8dcf22a2-c091-11e3-86f9-01aa75ed71a1/language-en
European Commission. 2018. Communication from the Commission to the European Parliament, the Council, The European Economic and Social Committee and the Committee of the Regions on enabling the digital transformation of health and care in the Digital Single Market; empowering citiz. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=COM%3A2018%3A233%3AFIN
Faulkner, A. 2008. Medical Technology into Healthcare and Society: A Sociology of Devices, Innovation and Governance. New York: Palgrave Macmillan (Health, Technology, and Governance).
Faulkner, A. 2012. Law’s performativities: shaping the emergence of regenerative medicine through European Union legislation. Social Studies of Science 42 (5): 753.
Faulkner, A. 2018. Blood Informatics: Negotiating the Regulation and Usership of Personal Devices for Medical Care and Recreational Self-monitoring. In Quantified Lives and Vital Data: Exploring Health and Technology through Personal Medical Devices, ed. R. Lynch and C. Farrington, 203–228. London: Palgrave Macmillan UK. https://doi.org/10.1057/978-1-349-95235-9_9.
Faulkner, A., and L. Poort. 2017. Stretching and challenging the boundaries of law: varieties of knowledge in biotechnologies regulation. Minerva 55 (2): 209–228.
FDA. 2013. Mobile Medical Applications Guidance for Industry and Food and Drug Administration Staff. https://www.fda.gov/media/80958/download
FDA. 2014. FDASIA Health IT Report. https://www.fda.gov/about-fda/cdrh-reports/fdasia-health-it-report
FDA. 2016. Final Guidance- General Wellness: Policy for Low Risk Devices. FDA Webinar. https://www.fda.gov/medical-devices/workshops-conferences-medical-devices/webinar-final-guidance-general-wellness-policy-low-risk-devices-september-1-2016
FDA. 2017a. Digital Health Innovation Action Plan. https://www.fda.gov/media/106331/download
FDA. 2017b. Software Precertification (Pre-Cert) Pilot Program - Frequently Asked Questions’. FDA Website. https://www.fda.gov/MedicalDevices/DigitalHealth/ucm570617.htm?...2017&utm_medium=email&utm_term=0_8f02c12568-e664e4ee02-90330813.
FDA. 2019. Policy for Device Software Functions and Mobile Medical Applications. Guidance for Industry and Food and Drug Administration Staff. https://www.fda.gov/media/80958/download
FDA. 2020a. 21st Century Cures Act. FDA Website. https://www.fda.gov/regulatory-information/selected-amendments-fdc-act/21st-century-cures-act
FDA. 2020b. Digital Health Policies and Public Health Solutions for COVID-19. https://www.fda.gov/medical-devices/coronavirus-covid-19-and-medical-devices/digital-health-policies-and-public-health-solutions-covid-19.
FDA. 2020c. Innovation to Respond to COVID-19. Learn about FDA’s innovative approaches to respond to COVID-19 as quickly and safely as possible. https://www.fda.gov/emergency-preparedness-and-response/coronavirus-disease-2019-covid-19/innovation-respond-covid-19.
FDA. 2021. Evaluation of Automatic Class III Designation (De Novo) Summaries. FDA Website. https://www.fda.gov/about-fda/cdrh-transparency/evaluation-automatic-class-iii-designation-de-novo-summaries
Federal Ministry of Health. 2019. Digital Healthcare Act (DVG). https://www.bundesgesundheitsministerium.de/digital-healthcare-act.html
Fornell, D. 2013. FDA offers Guidance on Explosion of Mobile Medical Apps. ITN News, 26 September. https://www.itnonline.com/article/fda-offers-guidance-explosion-mobile-medical-apps
Foucault, M. 2002. Power. Repr. London: Penguin (Essential works of Foucault 1954–1984 3).
Geiger, S., and N. Gross. 2017. Does hype create irreversibilities? Affective circulation and market investments in digital health. Marketing Theory 17 (4): 435–454.
Geiger, S., and H. Kjellberg. 2021. Market mashups: The process of combinatorial market innovation Forthcoming in Journal of Business Research Market mash ups: the process of combinatorial market innovation. Journal of Business Research. Online first.
Gold, A. 2015. Despite FDA moves, push continues for Congress to act on Mobile health. Politico, 11 February. https://www.politico.com/story/2015/02/fda-digital-health-companies-115113
Gottlieb, S. 2017. FDA Announces New Steps to Empower Consumers and Advance Digital Healthcare. FDA Voice. https://www.fda.gov/news-events/fda-voices/fda-announces-new-steps-empower-consumers-and-advance-digital-healthcare
Hendrickx, K. 2014. Bodies of Evidence. An Anthropology of the Health Claim. PhD thesis, Université de Liège, Liège, Belgium.
Hilts, P.J. 2003. Protecting America’s Health: The FDA, Business and One Hundred Years of Regulation. New York: Alfred A. Knopf.
Hilgartner, S. 2015. Capturing the Imaginary: Vanguards, Visions and the Synthetic Biology Revolution. In Science and Democracy, ed. S. Hilgartner, C.A. Miller, and R. Hagendijk, 33–55. London: Routledge.
Hogle, L.F. 2016a. Data-intensive resourcing in healthcare. BioSocieties 11: 372–393.
Hogle, L.F. 2016b. The Ethics and Politics of Infrastructures: Creating the Conditions of Possibility for Big Data in Medicine. In The Ethics of Biomedical Big Data, ed. B. Mittelstadt and L. Floridi, 397–427. New York: Springer.
Hogle, L.F., and A. Das. 2017. The social production of evidence: regenerative medicine and the 21st Century Cures Act. Regenerative Medicine 12 (6): 581–586.
Hogle, L. 2018. Intersections of Technological and Regulatory Zones in Regenerative Medicine. In Global Perspectives on Stem Cell Technologies, ed. A. Bharadwaj, 51–84. New York: Palgrave Macmillan.
IGES Institute. 2016. Digital Healthcare Products: Leveraging Opportunities – Developing Safe Routes to Market. https://www.iges.com/e6/e1621/ e10211/e13470/e15278/e15279/e15281/attr_objs15282/IGES_Publication_Digital_healthcare_ products_WEB_eng.pdf.
Irwin, A., H. Rothstein, S. Yearley, and E. McCarthy. 1997. Regulatory science—towards a sociological framework. Futures 29: 17–31.
Jasanoff, S. 1990. The Fifth Branch: Science Advisers as Policymakers. Cambridge: Harvard University Press.
Jasanoff, S. 2005. Designs on Nature: Science and Democracy in Europe and the United States. Princeton: Princeton University Press.
Joyce, Kelly. 2019. Smart textiles: Transforming the practice of medicalisation and health care. Sociology of Health & Illness 41 (S1): 147–161.
Kumar, S. 2019. Capitalising on Japan’s digital healthcare economy during this era of aging societies. HIMMS Europe. https://www.himss.eu/content/capitalising-japans-digital-healthcare-economy-during-era-aging-societies
Lezaun, J. 2006. Creating a new object of government: making genetically modified organisms traceable. Social Studies of Science. 36 (4): 499–531.
Lievevrouw, E., and I. Van Hoyweghen. 2019. The social implications of digital health technology. In Mobile health revolution in healthcare: Are We Ready? Metaforum KU Leuven, pp. 43–48. Available at https://www.kuleuven.be/metaforum/pdf/position-papers/2019-mobile-healthrevolution-in-healthcare
Lucivero, F., and B. Prainsack. 2015. The lifestylisation of healthcare? ‘Consumer genomics’ and mobile health as technologies for healthy lifestyle. Applied & Translational Genomics 4: 44–49.
Lynch, H.F., and G. Cohen. 2015. FDA in the Twenty-First Century: The Challenges of Regulating Drugs and New Technologies. New York: Columbia University Press.
Mackenzie, D., F. Muniesa, and L. Siu, eds. 2007. Do Economists Make Markets? On the Performativity of Economists. Princeton: Princeton University Press.
Marelli, Luca, Elisa Lievevrouw, and Ine Van Hoyweghen. 2020. Fit for purpose? The GDPR and the governance of European digital health. Policy Studies 41 (5): 447–467.
Maschke, K.J., and M.K. Gusmano. 2018. Debating Modern Medical Technologies: The Politics of Safety, Effectiveness, and Patient Access. Praeger.
Mcfall, L. 2010. Pragmatics and politics the case of industrial assurance in the UK. Journal of Cultural Economy 3 (2): 205–223.
McFall, L., G. Meyers, and I. Van Hoyweghen. 2020. The personalisation of insurance: Data, behaviour and innovation. Big Data & Society 7 (2): 1–11. https://doi.org/10.1177/2053951720973707.
Medicines & Healthcare products Regulatory Agency. 2014. Guidance: Medical Device Stand-alone Software Including Apps (including IVDMDs). https://www.gov.uk/government/publications/medical-devices-software-applications-apps
mHealth Regulatory Coalition (n.d.) About us. mHealth Regulatory Coalition Website. http://mhealthregulatorycoalition.org/about-us/
Montgomery, K., J. Chester, and K. Kopp. 2017. Health Wearable Devices in the Big Data Era: Ensuring Privacy, Security, and Consumer Protection. https://www.democraticmedia.org/CDD-Wearable-Devices-Big-Data-Report
Mikulic, M. 2020. Global digital health market size 2019 and 2026 forecast. Statistica.com, https://www.statista.com/statistics/1092869/global-digital-health-market-size-forecast/
Ministry of Health Singapore. 2019. Licensing Experimentation and Adaptation Programme (LEAP)—A Regulatory Sandbox. https://www.moh.gov.sg/our-healthcare-system/licensing-experimentation-and-adaptation-programme-(leap)---a-moh-regulatory-sandbox
National Institute for Health and Care Excellence. 2019. Evidence Standards Framework for Digital Health Technologies. UK, National Institute for Health and Care Excellence (NICE) https://www.nice.org.uk/about/what-we-do/our-programmes/evidence-standards-framework-for-digital-health-technologies
Neff, G., and D. Nafus. 2016. Self-Tracking. Cambridge: The MIT Press.
Norman, B. 2012. FDA and medical-apps makers tussle. Politico, 16 April. https://www.politico.com/story/2012/04/fda-tangles-with-wireless-medical-app-makers-075207
Latour, B. 1987. Science in Action. Boston: Harvard University Press.
Lupton, D. 2013. The digitally engaged patient: self-monitoring and self-care in the digital health era. Social Theory and Health 11 (3): 256–270.
Lupton, D. 2017. Digital Health Critical and Cross-Disciplinary Perspectives. London: Taylor & Francis.
Lynch, H.F., and I.G. Cohen, eds. 2015. FDA in the Twenty-First Century. The Challenges of Regulating Drugs and New Technologies. New York: Columbia University Press.
OECD. 2017. New Health Technologies: Managing Access, Value and Sustainability. Paris: OECD.
OECD. 2019. Health in the 21st Century PUTTING DATA TO WORK FOR STRONGER HEALTH SYSTEMS, OECD Health Policy Studies. https://www.oecd-ilibrary.org/social-issues-migration-health/health-in-the-21st-century_e3b23f8e-en
Official Journal of the European Union. 2017a. Regulation (EU) 2017/745 of the European Parliament and the Council of 5 April 2017 on Medical Devices, Amending Directive 2001/83/ EC, Regulation (EC) No 178/2002 and Regulation (EC) No 1223/2009 and Repealing Council Directives 90/385/EEC and 93/42/EEC. https://eur-lex.europa. eu/legal-content/EN/TXT/?uri=CELEX%3A32017R0745
Official Journal of the European Union. 2017b. Regulation (EU) 2017/746 of the European Parliament and of the Council of 5 April 2017 on in Vitro Diagnostic Medical Devices and Repealing Directive 98/79/EC and Commission Decision 2010/227/EU. https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A32017R0746
Ordish, J., M. Hannah, and H. Allison. 2019. Algorithms as medical devices. PHG Foundation. https://www.phgfoundation.org/report/algorithms-as-medical-devices
Pickersgill, M. 2019. Digitising psychiatry? Sociotechnical expectations, performative nominalism and biomedical virtue in (digital) psychiatric praxis. Sociology of Health and Illness 41 (S1): 16–30.
PwC. 2013. Socio-economic impact of mHealth: An assessment report for the European Union. https://www.pwc.in/publications/publications-2013/socio-economic-impact-of-mhealth-an-assessment-report-for-the-european-union.html
PwC. 2014. The Wearable Future. https://www.pwc.ru/en/retail-consumer/publications/assets/pwc-cis-wearable-future.pdf.
Rich, Emma, Andy Miah, and Sarah Lewis. 2019. Is digital health care more equitable? The framing of health inequalities within England’s digital health policy 2010–2017. Sociology of Health and Illness 41 (S1): 31–49.
Roland Berger. 2016. Think Act: Digital and Disrupted. All change for healthcare. How can Pharma companies flourish in a digitized healthcare world? https://www.rolandberger.com/en/Media/Digital-health-market-to-average-21-percent-growth-per-year-through-2020.html.
Sharon, T. 2016. The Googlization of health research: from disruptive innovation to disruptive ethics. Personalized Medicine 13 (6): 563–574.
Tavernise, S. 2013. FDA to regulate Some Health Apps. The New York Times, 23 September. https://www.nytimes.com/2013/09/24/health/fda-to-regulate-only-some-health-apps.html
Thompson, D. 2016. Congress passes 21st Century Cures Act with billions for new research, treatments. CBS News, 8 December. https://www.cbsnews.com/news/21st-century-cures-act-congress-health-care-passed/
Ulucanlar, S., A. Faulkner, S. Pierce, and G. Elwyn. 2013. Technology identity: the role of sociotechnical representations in the adoption of medical devices. Social Science & Medicine 98: 95–105.
van Dijck, J., T. Poell, and M. de Waal. 2018. The Platform Society. Oxford: Oxford University Press.
van Lente, H., C. Spitters, and A. Peine. 2013. Comparing technological hype cycles: towards a theory. Technological Forecasting & Social Change 80 (8): 1615–1628.
Webster, A. 2007. Health Technology and Society: A Sociological Critique. Basingstoke: Palgrave Macmillan.
Webster, A. 2019. Accelerating innovation: complexity, regulation, and temporality. Frontiers in Sociology. https://doi.org/10.3389/fsoc.2019.00013.
White, S.K., and A.N. Walters. 2018. Assessing risk by analogy: a case study of us medical device risk management policy. Health, Risk & Society 20 (7–8): 358–378.
WHO Director-General. 2017. mHealth: Use of Appropriate Digital Technologies for Public Health. World Health Organization, https://apps.who.int/iris/handle/10665/274134
Wodajo, F. 2011. How the iPad radiology app Mobile MIM became the first to get FDA approval: Interview with CTO Mark Cain. iMedicalApps Medpage Today.
Wong, J.C. 2018. Birth control app reported to Swedish officials after 37 unwanted pregnancies. The Guardian, 17 January: https://www.theguardian.com/technology/2018/jan/17/birth-control-app-natural-cycle-pregnancies